.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Predict branded drug patent expiration
  • Identify first generic entrants

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Teva
Cerilliant
Daiichi Sankyo
Colorcon
Accenture
Medtronic
Queensland Health
Mallinckrodt
Federal Trade Commission

Generated: June 27, 2017

DrugPatentWatch Database Preview

Ofloxacin - Generic Drug Details

« Back to Dashboard

What are the generic sources for ofloxacin and what is the scope of ofloxacin freedom to operate?

Ofloxacin
is the generic ingredient in six branded drugs marketed by Akorn, Apotex Inc, Hi Tech Pharma, Ranbaxy Labs Ltd, Allergan, Bausch And Lomb, Sandoz Inc, Alvogen, Janssen Pharms, Sandoz, Cadila Pharms Ltd, Fdc Ltd, Bedford, Teva, Ortho Mcneil Pharm, Altaire Pharms Inc, Larken Labs, Dr Reddys Labs Ltd, and Daiichi, and is included in twenty-four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are seventy drug master file entries for ofloxacin. Thirty-two suppliers are listed for this compound. There is one tentative approval for this compound.

Summary for Generic Name: ofloxacin

Tradenames:6
Patents:1
Applicants:19
NDAs:24
Drug Master File Entries: see list70
Suppliers / Packagers: see list32
Bulk Api Vendors: see list76
Clinical Trials: see list24
Patent Applications: see list6,117
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ofloxacin at DailyMed

Pharmacology for Ingredient: ofloxacin

Ingredient-typeQuinolones
Drug ClassQuinolone Antimicrobial

Tentative approvals for OFLOXACIN

Applicant Application No. Strength Dosage Form
► Subscribe► Subscribe200MGTABLET;ORAL
► Subscribe► Subscribe400MGTABLET;ORAL
► Subscribe► Subscribe300MGTABLET;ORAL
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Inc
OFLOXACIN
ofloxacin
SOLUTION/DROPS;OPHTHALMIC076513-001May 14, 2004DISCNNoNo► Subscribe► Subscribe
Larken Labs
OFLOXACIN
ofloxacin
TABLET;ORAL076093-002Sep 2, 2003DISCNNoNo► Subscribe► Subscribe
Daiichi
FLOXIN OTIC
ofloxacin
SOLUTION/DROPS;OTIC020799-001Dec 16, 1997DISCNYesNo► Subscribe► Subscribe
Teva
OFLOXACIN
ofloxacin
TABLET;ORAL076182-001Sep 2, 2003ABRXNoNo► Subscribe► Subscribe
Bausch And Lomb
OFLOXACIN
ofloxacin
SOLUTION/DROPS;OTIC076128-001Mar 17, 2008ATRXNoYes► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ofloxacin

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Janssen Pharms
FLOXIN
ofloxacin
TABLET;ORAL019735-002Dec 28, 19904,382,892► Subscribe
Daiichi
FLOXIN OTIC
ofloxacin
SOLUTION/DROPS;OTIC020799-001Dec 16, 19975,401,741► Subscribe
Ortho Mcneil Pharm
FLOXIN
ofloxacin
INJECTABLE;INJECTION020087-002Mar 31, 19924,382,892► Subscribe
Allergan
OCUFLOX
ofloxacin
SOLUTION/DROPS;OPHTHALMIC019921-001Jul 30, 19934,382,892*PED► Subscribe
Janssen Pharms
FLOXIN
ofloxacin
TABLET;ORAL019735-001Dec 28, 19904,382,892► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
Baxter
Daiichi Sankyo
Merck
Deloitte
Mallinckrodt
Queensland Health
Teva
Boehringer Ingelheim
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot